Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal...

Area of Science:

• Immunology
• Neurovirology

Background:

• Progressive multifocal leukoencephalopathy (PML) is a serious demyelinating disease of the central nervous system.
• The cellular immune response plays a critical role in controlling JC virus (JCV) replication and PML progression.
• Immune exhaustion, marked by Programmed cell death-1 (PD-1) expression, can impair T-cell function.

Purpose of the Study:

• To investigate PD-1 expression on T lymphocytes in patients with PML.
• To assess the impact of PD-1 expression on JC virus (JCV)-specific T cells in PML.
• To explore the therapeutic potential of PD-1 blockade in PML.

Main Methods:

• Flow cytometry was used to quantify PD-1 expression on CD4(+) and CD8(+) T cells in PML patients and healthy controls.
• JC virus (JCV)-specific CD8(+) cytotoxic T lymphocytes were identified and analyzed for PD-1 expression.
• The effect of PD-1 receptor blockade on JCV-specific T-cell immune response was evaluated in a subset of PML patients.

Main Results:

• PD-1 expression was significantly higher on total CD4(+) and CD8(+) T cells in PML patients compared to healthy controls.
• JCV-specific CD8(+) cytotoxic T lymphocytes exhibited higher PD-1 expression than total CD8(+) T cells in PML patients.
• Blocking the PD-1 receptor enhanced the JCV-specific T-cell immune response in some PML patients.

Conclusions:

• Elevated PD-1 expression on T cells indicates cellular immune exhaustion in PML.
• Targeting the PD-1 pathway may represent a viable therapeutic strategy to restore anti-JCV immunity in PML.